TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Isofol Medical AB (publ)
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
484
|
8,551
|
16,293 |
| Financial expenses |
7
|
29
|
122 |
| Earnings before taxes |
-24,900
|
-106,754
|
-145,609 |
| EBITDA |
-27,973
|
-110,805
|
-147,512 |
| Total assets |
94,435
|
142,644
|
291,844 |
| Current assets |
94,433
|
139,962
|
286,933 |
| Current liabilities |
12,261
|
34,571
|
60,367 |
| Equity capital |
81,563
|
105,901
|
231,396 |
| - share capital |
3,321
|
3,304
|
3,596 |
| Employees (average) |
5
|
14
|
13 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
86.4%
|
74.2%
|
79.3% |
| Turnover per employee |
97
|
611
|
1,253 |
| Profit as a percentage of turnover |
-5144.6%
|
-1248.4%
|
-893.7% |
| Return on assets (ROA) |
-26.4%
|
-74.8%
|
-49.9% |
| Current ratio |
770.2%
|
404.9%
|
475.3% |
| Return on equity (ROE) |
-30.5%
|
-100.8%
|
-62.9% |
| Change turnover | |||
| Change turnover % |
-43%
|
-40% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
8%
|
8% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.